Phenol
In clinical developmentAlso known as Acide carbolique, Acide phénique, Benzenol, Calamine-Phenol+26 more
Acide carbolique, Acide phénique, Benzenol, Calamine-Phenol, Campho-Phenique, Camphor and Phenol, Carbolic acid, Carbolsäure, Castellani Paint, Cepastat, Cheracol Sore Throat, Chloraseptic Max Spray, Chloraseptic Spray, Fenol, Hydroxybenzene, Karbolsäure, Monohydroxybenzene, Mycinette Sore Throat Spray, Ora Relief, Oxybenzene, PHOH, Pain-A-Lay Gargle, Phenic Acid, Phenyl alcohol, Phenyl hydroxide, Phenylic acid, Phenylic alcohol, UlcerEase, Unguentine, Unguentine Maximum Strength.
Recent clinical, regulatory, research and industry developments relating to this drug.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Medicine1
- Abe I1
- Abe M1
- Fujita Y1
- Kobayashi K1
- Koga M1
- Kudo T1
- Mukoubara S1
- Nagata M1
- Clinical Research Support Center1
- Fukuoka University1
- Fukuoka University Chikushi Hospital1
- Nagasaki Prefecture Iki Hospital1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials